volociximab
information and resources from the National Cancer Institute
NCI Thesaurus | volociximab
A chimeric monoclonal antibody with potential antineoplastic activity. Volociximab binds to and inhibits the activity of alpha(5)beta(1) integrin, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis. NCI Thesaurus | volociximab
A chimeric monoclonal antibody with potential antineoplastic activity. Volociximab binds to and inhibits the activity of alpha(5)beta(1) integrin, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis.
|
|
|
|
news articles
Biogen Idec Reports Third Quarter 2005 Results Oct 26, 2005
Business Wire (press release), ...in MS and indications other than transplant and respiratory diseases, and for shared development and commercialization of M200 (volociximab) and HuZAF(TM ...
|
|
